Tools & Wizards About Us
drugresearcher.com screenshot

Report Summary

  • 28

    Performance

    Renders faster than
    48% of other websites

  • 87

    Accessibility

    Visual factors better than
    that of 67% of websites

  • 83

    Best Practices

    More advanced features
    available than in
    56% of websites

  • 85

    SEO

    Google-friendlier than
    56% of websites

drugresearcher.com

Pharmaceutical Supply, Pharmaceutical Manufacturing, Contract Research, Pharmaceutical Outsourcing

Page Load Speed

4.3 sec in total

First Response

195 ms

Resources Loaded

3.4 sec

Page Rendered

767 ms

drugresearcher.com screenshot

About Website

Visit drugresearcher.com now to see the best up-to-date Drug Research Er content and also check out these interesting facts you probably never knew about drugresearcher.com

Daily news on pharmaceutical outsourcing. Free access to news on pharmaceutical supply, pharmaceutical manufacturing, contract research and pharmaceutical services

Visit drugresearcher.com

Key Findings

We analyzed Drugresearcher.com page load time and found that the first response time was 195 ms and then it took 4.1 sec to load all DOM resources and completely render a web page. This is a poor result, as 65% of websites can load faster.

Performance Metrics

drugresearcher.com performance score

28

Measured Metrics

name

value

score

weighting

FCP (First Contentful Paint)

Value3.3 s

39/100

10%

LCP (Largest Contentful Paint)

Value7.5 s

4/100

25%

SI (Speed Index)

Value5.7 s

51/100

10%

TBT (Total Blocking Time)

Value1,140 ms

22/100

30%

CLS (Cumulative Layout Shift)

Value0.161

73/100

15%

TTI (Time to Interactive)

Value15.3 s

7/100

10%

Network Requests Diagram

drugresearcher.com

195 ms

www.outsourcing-pharma.com

297 ms

57593c3e5ccc207f694e175d5a660fed_1454493222_all.css

271 ms

error.js

141 ms

8d68b43f88fec9c986e78d93dedd038b_1450366373.js

432 ms

Our browser made a total of 110 requests to load all elements on the main page. We found that 1% of them (1 request) were addressed to the original Drugresearcher.com, 44% (48 requests) were made to Outsourcing-pharma.com and 10% (11 requests) were made to Sas.decisionnews.com. The less responsive or slowest element that took the longest time to load (768 ms) relates to the external source Outsourcing-pharma.com.

Page Optimization Overview & Recommendations

Page size can be reduced by 669.6 kB (47%)

Content Size

1.4 MB

After Optimization

761.9 kB

  • HTML
  • Images
  • JavaScript
  • CSS

In fact, the total size of Drugresearcher.com main page is 1.4 MB. This result falls beyond the top 1M of websites and identifies a large and not optimized web page that may take ages to load. 65% of websites need less resources to load. Images take 575.7 kB which makes up the majority of the site volume.

HTML Optimization

-82%

Potential reduce by 100.1 kB

  • Original 122.3 kB
  • After minification 102.0 kB
  • After compression 22.2 kB

HTML content can be minified and compressed by a website’s server. The most efficient way is to compress content using GZIP which reduces data amount travelling through the network between server and browser. This page needs HTML code to be minified as it can gain 20.3 kB, which is 17% of the original size. It is highly recommended that content of this web page should be compressed using GZIP, as it can save up to 100.1 kB or 82% of the original size.

Image Optimization

-4%

Potential reduce by 24.6 kB

  • Original 575.7 kB
  • After minification 551.0 kB

Image size optimization can help to speed up a website loading time. The chart above shows the difference between the size before and after optimization. Drug Research Er images are well optimized though.

JavaScript Optimization

-72%

Potential reduce by 412.1 kB

  • Original 574.4 kB
  • After minification 536.6 kB
  • After compression 162.3 kB

It’s better to minify JavaScript in order to improve website performance. The diagram shows the current total size of all JavaScript files against the prospective JavaScript size after its minification and compression. It is highly recommended that all JavaScript files should be compressed and minified as it can save up to 412.1 kB or 72% of the original size.

CSS Optimization

-83%

Potential reduce by 132.8 kB

  • Original 159.1 kB
  • After minification 157.1 kB
  • After compression 26.3 kB

CSS files minification is very important to reduce a web page rendering time. The faster CSS files can load, the earlier a page can be rendered. Drugresearcher.com needs all CSS files to be minified and compressed as it can save up to 132.8 kB or 83% of the original size.

Requests Breakdown

Number of requests can be reduced by 42 (42%)

Requests Now

100

After Optimization

58

  • AJAX
  • Images
  • JavaScript
  • CSS

The browser has sent 100 CSS, Javascripts, AJAX and image requests in order to completely render the main page of Drug Research Er. We recommend that multiple CSS and JavaScript files should be merged into one by each type, as it can help reduce assets requests from 29 to 1 for JavaScripts and as a result speed up the page load time.

Network Requests Diagram

drugresearcher.com

drugresearcher.com

195 ms

www.outsourcing-pharma.com

www.outsourcing-pharma.com

297 ms

57593c3e5ccc207f694e175d5a660fed_1454493222_all.css

57593c3e5ccc207f694e175d5a660fed_1454493222_all.css

271 ms

error.js

error.js

141 ms

8d68b43f88fec9c986e78d93dedd038b_1450366373.js

8d68b43f88fec9c986e78d93dedd038b_1450366373.js

432 ms

doc_loaded.js

doc_loaded.js

196 ms

gBCR3quGEeSEgwp+lcGdIw.js

gBCR3quGEeSEgwp+lcGdIw.js

14 ms

Homepage_strict_xxl.jpg

Homepage_strict_xxl.jpg

520 ms

Miltenyi-Biotec-to-help-GSK-automate-R-D-cell-therapy-production_regular_f.jpg

Miltenyi-Biotec-to-help-GSK-automate-R-D-cell-therapy-production_regular_f.jpg

188 ms

Covance-launches-app-assessment-service-for-sponsors_regular_f.jpg

Covance-launches-app-assessment-service-for-sponsors_regular_f.jpg

293 ms

BIA-10-2474-Expert-calls-for-better-pharmacology-before-protocols-are-approved_regular_f.jpg

BIA-10-2474-Expert-calls-for-better-pharmacology-before-protocols-are-approved_regular_f.jpg

294 ms

Valeant-divesting-non-core-Synergetics-CMO-business_regular_f.jpg

Valeant-divesting-non-core-Synergetics-CMO-business_regular_f.jpg

294 ms

TxCell-names-PCT-as-Ovasave-contract-manufacturer-in-the-US_regular_f.jpg

TxCell-names-PCT-as-Ovasave-contract-manufacturer-in-the-US_regular_f.jpg

354 ms

AAI-and-CML-rebrand-as-Alcami_regular_f.jpg

AAI-and-CML-rebrand-as-Alcami_regular_f.jpg

376 ms

Impurity-isolation-and-sample-purification_regular_f.jpg

Impurity-isolation-and-sample-purification_regular_f.jpg

384 ms

overlay_0.png

overlay_0.png

382 ms

China-and-the-Process-for-Importation-of-Clinical-Trial-Drugs_regular_f.jpg

China-and-the-Process-for-Importation-of-Clinical-Trial-Drugs_regular_f.jpg

516 ms

EFPIA-Protecting-the-European-Meds-Verification-System-from-fakers-is-vital_regular_f.jpg

EFPIA-Protecting-the-European-Meds-Verification-System-from-fakers-is-vital_regular_f.jpg

518 ms

US-FDA-questions-facility-design-in-Warning-Letter-for-Emcure_regular_f.jpg

US-FDA-questions-facility-design-in-Warning-Letter-for-Emcure_regular_f.jpg

518 ms

Time-saving-benefit-a-factor-in-decision-to-go-disposable-says-Avid_regular_f.jpg

Time-saving-benefit-a-factor-in-decision-to-go-disposable-says-Avid_regular_f.jpg

518 ms

Gyros-and-Protein-Technologies-to-create-end-to-end-biopeptide-firm_regular_f.jpg

Gyros-and-Protein-Technologies-to-create-end-to-end-biopeptide-firm_regular_f.jpg

519 ms

3D-culturing-key-to-cell-therapy-offered-to-Fukushima-clean-up-workers_regular_f.jpg

3D-culturing-key-to-cell-therapy-offered-to-Fukushima-clean-up-workers_regular_f.jpg

529 ms

Societal-cost-for-cheap-antibiotics-from-polluting-suppliers-says-DSP_regular_f.jpg

Societal-cost-for-cheap-antibiotics-from-polluting-suppliers-says-DSP_regular_f.jpg

547 ms

China-modifies-bioequivalence-testing-rules-and-sets-new-deadlines_regular_f.jpg

China-modifies-bioequivalence-testing-rules-and-sets-new-deadlines_regular_f.jpg

566 ms

Pfizer-invests-21m-in-Australian-pegfilgrastim-plant_regular_f.jpg

Pfizer-invests-21m-in-Australian-pegfilgrastim-plant_regular_f.jpg

580 ms

Mexico-office-to-bolster-CRO-Eurotrials-presence-in-Latin-America_regular_f.jpg

Mexico-office-to-bolster-CRO-Eurotrials-presence-in-Latin-America_regular_f.jpg

574 ms

CTI-Biopharma-confirms-a-CRO-is-involved-in-Ph-III-trial-halted-after-deaths_regular_f.jpg

CTI-Biopharma-confirms-a-CRO-is-involved-in-Ph-III-trial-halted-after-deaths_regular_f.jpg

602 ms

Amgen-selects-Patheon-as-a-strategic-manufacturing-partner_regular_f.jpg

Amgen-selects-Patheon-as-a-strategic-manufacturing-partner_regular_f.jpg

619 ms

Twitter-for-ClinicalTrials-recruitment-Researchers-see-the-potential_regular_f.jpg

Twitter-for-ClinicalTrials-recruitment-Researchers-see-the-potential_regular_f.jpg

641 ms

Tufts-examines-2.87bn-drug-development-cost_regular_f.jpg

Tufts-examines-2.87bn-drug-development-cost_regular_f.jpg

662 ms

Ebola-researcher-Future-epidemic-trials-must-cut-through-red-tape_regular_f.jpg

Ebola-researcher-Future-epidemic-trials-must-cut-through-red-tape_regular_f.jpg

668 ms

play_text_0.png

play_text_0.png

673 ms

CROs-need-to-educate-consumers-on-clinical-trials_related_news_other.jpg

CROs-need-to-educate-consumers-on-clinical-trials_related_news_other.jpg

687 ms

Lack-of-enforcement-means-one-third-of-US-trials-unreported-study_related_news_other.jpg

Lack-of-enforcement-means-one-third-of-US-trials-unreported-study_related_news_other.jpg

705 ms

Preclinical-consolidation-creates-service-desert-Swiss-CRO-Anapath_related_news_other.jpg

Preclinical-consolidation-creates-service-desert-Swiss-CRO-Anapath_related_news_other.jpg

736 ms

Unpublished-trial-results-the-blind-spot-in-the-clinical-research_related_news_other.jpg

Unpublished-trial-results-the-blind-spot-in-the-clinical-research_related_news_other.jpg

756 ms

Researchers-doing-wrong-things-more-efficiently_related_news_other.jpg

Researchers-doing-wrong-things-more-efficiently_related_news_other.jpg

763 ms

Johnson-and-Johnson-opens-incubator-to-accelerate-early-stage-research_related_news_other.jpg

Johnson-and-Johnson-opens-incubator-to-accelerate-early-stage-research_related_news_other.jpg

768 ms

wrbm-footer.js

wrbm-footer.js

209 ms

log

log

731 ms

_blank.gif

_blank.gif

718 ms

body.png

body.png

323 ms

common.png

common.png

340 ms

188 ms

show1.asp

show1.asp

97 ms

sas-browser.js

sas-browser.js

11 ms

jsinfo.asp

jsinfo.asp

85 ms

sas-dom.js

sas-dom.js

11 ms

sas-banner-2.1.js

sas-banner-2.1.js

4 ms

ALT-15-048-Banner-970x90.jpg

ALT-15-048-Banner-970x90.jpg

17 ms

all.js

all.js

271 ms

117 ms

common.png

common.png

98 ms

common.png

common.png

106 ms

common_2.png

common_2.png

97 ms

dot.png

dot.png

89 ms

dot2.png

dot2.png

94 ms

93 ms

show2.asp

show2.asp

104 ms

137 ms

xd_arbiter.php

xd_arbiter.php

218 ms

xd_arbiter.php

xd_arbiter.php

475 ms

DPT__300X250_1-26-16_V1_March_2016.jpg

DPT__300X250_1-26-16_V1_March_2016.jpg

176 ms

88 ms

follow_button.html

follow_button.html

70 ms

linkedin-group.png

linkedin-group.png

104 ms

platform.js

platform.js

116 ms

jot

jot

148 ms

info.json

info.json

144 ms

show0.asp

show0.asp

110 ms

cb=gapi.loaded_0

cb=gapi.loaded_0

10 ms

cb=gapi.loaded_1

cb=gapi.loaded_1

40 ms

follow

follow

130 ms

postmessageRelay

postmessageRelay

55 ms

10083-Fisher-Clinical-ServicesResize(0).jpg

10083-Fisher-Clinical-ServicesResize(0).jpg

29 ms

Calendar-50.jpg

Calendar-50.jpg

125 ms

icons.png

icons.png

118 ms

wrbm.png

wrbm.png

100 ms

3193398744-postmessagerelay.js

3193398744-postmessagerelay.js

166 ms

rpc:shindig_random.js

rpc:shindig_random.js

85 ms

country-code

country-code

180 ms

rs=AGLTcCP2JMlJRxhNp5DO7Vleg1JbOAkkRg

rs=AGLTcCP2JMlJRxhNp5DO7Vleg1JbOAkkRg

19 ms

rs=AGLTcCPeW_yxohM6d2vzOu9_v18SNdO9Aw

rs=AGLTcCPeW_yxohM6d2vzOu9_v18SNdO9Aw

25 ms

rs=AGLTcCOYYgQ3JxVNs4OscPZY6LDahwt1EA

rs=AGLTcCOYYgQ3JxVNs4OscPZY6LDahwt1EA

85 ms

166 ms

W5F8_SL0XFawnjxHGsZjJA.ttf

W5F8_SL0XFawnjxHGsZjJA.ttf

120 ms

dtpHsbgPEm2lVWciJZ0P-A.ttf

dtpHsbgPEm2lVWciJZ0P-A.ttf

124 ms

bdHGHleUa-ndQCOrdpfxfw.ttf

bdHGHleUa-ndQCOrdpfxfw.ttf

132 ms

cb=gapi.loaded_0

cb=gapi.loaded_0

15 ms

show5.asp

show5.asp

97 ms

pixel.gif

pixel.gif

191 ms

pix-bg.png

pix-bg.png

52 ms

header_envelope.png

header_envelope.png

43 ms

close.png

close.png

52 ms

popup_FN_bttn.png

popup_FN_bttn.png

52 ms

envelope2.png

envelope2.png

52 ms

OSP.png

OSP.png

64 ms

95 ms

gtm.js

gtm.js

78 ms

ping

ping

56 ms

analytics.js

analytics.js

5 ms

conversion_async.js

conversion_async.js

23 ms

collect

collect

15 ms

collect

collect

17 ms

36 ms

like.php

like.php

85 ms

collect

collect

57 ms

31 ms

TY3MhkXpWJ-.js

TY3MhkXpWJ-.js

487 ms

LVx-xkvaJ0b.png

LVx-xkvaJ0b.png

551 ms

Accessibility Review

drugresearcher.com accessibility score

87

Accessibility Issues

Contrast

These are opportunities to improve the legibility of your content.

Impact

Issue

High

Background and foreground colors do not have a sufficient contrast ratio.

Names and labels

These are opportunities to improve the semantics of the controls in your application. This may enhance the experience for users of assistive technology, like a screen reader.

Impact

Issue

High

Image elements do not have [alt] attributes

High

Links do not have a discernible name

Tables and lists

These are opportunities to improve the experience of reading tabular or list data using assistive technology, like a screen reader.

Impact

Issue

High

Lists do not contain only <li> elements and script supporting elements (<script> and <template>).

Best Practices

drugresearcher.com best practices score

83

Areas of Improvement

Trust and Safety

Impact

Issue

High

Does not use HTTPS

High

Includes front-end JavaScript libraries with known security vulnerabilities

Low

Ensure CSP is effective against XSS attacks

General

Impact

Issue

Low

Detected JavaScript libraries

High

Page has valid source maps

SEO Factors

drugresearcher.com SEO score

85

Search Engine Optimization Advices

Crawling and Indexing

To appear in search results, crawlers need access to your app.

Impact

Issue

High

Links are not crawlable

Content Best Practices

Format your HTML in a way that enables crawlers to better understand your app’s content.

Impact

Issue

High

Image elements do not have [alt] attributes

Mobile Friendly

Make sure your pages are mobile friendly so users don’t have to pinch or zoom in order to read the content pages. [Learn more](https://developers.google.com/search/mobile-sites/).

Impact

Issue

High

Document uses legible font sizes

High

Tap targets are not sized appropriately

Language and Encoding

  • Language Detected

    EN

  • Language Claimed

    EN

  • Encoding

    UTF-8

Language claimed in HTML meta tag should match the language actually used on the web page. Otherwise Drugresearcher.com can be misinterpreted by Google and other search engines. Our service has detected that English is used on the page, and it matches the claimed language. Our system also found out that Drugresearcher.com main page’s claimed encoding is utf-8. Use of this encoding format is the best practice as the main page visitors from all over the world won’t have any issues with symbol transcription.

Social Sharing Optimization

drugresearcher.com

Open Graph data is detected on the main page of Drug Research Er. This is the best way to make the web page social media friendly. Here is how it looks like on Facebook: